S Manjula
S Manjula publishes mostly in Molecular Biology, Plant Science and Endocrinology, Diabetes and Metabolism, on topics such as Bioactive Compounds and Antitumor Agents, Blood Pressure and Hypertension Studies and Diabetes Management and Education.
- World rank
- #3,041,069 of 7,710,434 ranked researchers
- Rank in India
- #62,727 of 280,097
- Works
- 122
- Citations
- 7k
- Citations per work
- 57.0
What does S Manjula research?
S Manjula's work is mostly in Medicine (13%), Biochemistry, Genetics and Molecular Biology (8%), Agricultural and Biological Sciences (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else8569.6%
- Life Sciences1714.2%
- Health Sciences1613.0%
- Medicine1613.0%
- Physical Sciences43.2%
- Chemistry43.2%
- 1Molecular Biology8% of their works
- 2Plant Science6% of their works
- 3Endocrinology, Diabetes and Metabolism6% of their works
- 4Epidemiology4% of their works
- 5Pharmacology4% of their works
- 6Organic Chemistry3% of their works
Research topics
- Bioactive Compounds and Antitumor Agents
- Blood Pressure and Hypertension Studies
- Diabetes Management and Education
- Epilepsy research and treatment
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Practices and Patient Outcomes
Which keywords describe S Manjula's research?
The keywords of their largest research topics: Cardiovascular Disease, Diabetes, Glycemic Control, Clinical Guidelines, Insulin Therapy, Quinones, Toxicology and Blood Pressure.
- Polypharmacy
- Insulin Resistance
- Hypoglycemia
- Cardiovascular Outcomes
- Seizures
- Epilepsy
- Blood Pressure
- Quinones
- Clinical Guidelines
- Diabetes
- Cardiovascular Disease
- Glycemic Control
- Insulin Therapy
- Toxicology
- Depression
- Hypertension
- Self-Management
- Continuous Glucose Monitoring
- Inappropriate Medication Use
- Metabolic Syndrome
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cardiovascular Disease133 topics
- Diabetes133 topics
- Glycemic Control133 topics
- Clinical Guidelines92 topics
- Insulin Therapy82 topics
- Quinones61 topic
- Toxicology61 topic
- Blood Pressure51 topic
- Depression51 topic
- Epilepsy51 topic
- Hypertension51 topic
- Seizures51 topic
- Self-Management51 topic
- Cardiovascular Outcomes41 topic
- Continuous Glucose Monitoring41 topic
- Hypoglycemia41 topic
- Inappropriate Medication Use41 topic
- Insulin Resistance41 topic
- Metabolic Syndrome41 topic
- Polypharmacy41 topic
- Type 2 Diabetes41 topic
Where does S Manjula work?
S Manjula's main affiliation in the publication record is Micro Labs (India), India.
How many publications and citations does S Manjula have?
OpenAlex counts 122 works and 6,952 citations for S Manjula, an h-index of 21, ranking #3,041,069 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named S Manjula
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about S Manjula. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.